Viewing data from:

AMIKACIN SULFATE

ANDA

AMIKACIN SULFATE | A218146 | QILU PHARMACEUTICAL CO LTD

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 1 NDC

Highest NADAC/Unit

$2.27

per ml

Lowest NADAC/Unit

$2.27

per ml

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
83301002202AMIKACIN SULF 500 MG/2 ML VIAL	$2.27	ML	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain2 active DMFs7 inactive

2 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

ACS DOBFAR SPAAMIKACIN SULFATE

DMF 137631998

SHANDONG ANXIN PHARMACEUTICAL CO LTDAMIKACIN SULFATE USP, NON-STERILE ACTIVE PHARMACEUTICAL INGREDIENT

DMF 208742007

CHEMICAL PHARMACEUTICAL RESEARCH INSTITUTE NIHFI LTDInactiveAMIKACIN SULFATE

DMF 106801993

GIST-BROCADES NV PHARMACEUTICALSInactiveAMIKACIN SULFATE

DMF 136511998

BRISTOL MYERS SQUIBB COInactiveAMIKACIN SULFATE

DMF 137221998

ABBOTT LABORATORIESInactiveAMIKACIN SULFATE

DMF 137561998

CHONGQING DAXIN PHARMACEUTICAL CO LTDInactiveAMIKACIN SULFATE (1:2) USP

DMF 137881998

PKUCARE CHONGQING DAXIN PHARMACEUTICAL CO LTDInactiveAmikacin Sulfate (1:1.8) USP, Non-Sterile Bulk Drug Substance

DMF 210352007

ZHEJIANG JINHUA CONBA BIO-PHARM CO LTDInactiveAMIKACIN SULFATE USP

DMF 277762013

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — EQ 250MG BASE/ML

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Mar 19, 2024

No patent or exclusivity listings for this strength.